NM23-H1 immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas

British Journal of Cancer

Volumn 77, Issue 7, 1998, Pages 1164-1168

  Cheah, P Y ^a   Cao, X ^a   Eu, K W ^a   Seow Choen, F ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Colorectal cancer; Immunohistochemistry; Metastasis; NM23 H1

Indexed keywords

GENE PRODUCT; NUCLEOSIDE DIPHOSPHATE KINASE A; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX; SURVIVAL TIME; TUMOR DIFFERENTIATION;

EID: 0031905677     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.193     Document Type: Article

References (22)

1. Cawkwell L, Lewis FA and Quirke P (1994) Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by flourescent multiplex polymerase chain reaction. Br J Cancer 70: 813-818
2. Cohn KH, Wang F, Desoto-Lapaix F, Solomon WB, Patterson LG, Arnold MR, Weimar J, Feldman JG and Levy AT (1991) Association of nm23-H1 allelic deletions with distinct metastasis in colorectal carcinoma. Lancet 338: 722-724
3. Cohn KH, Ornstein DL, Wang F, Desoto-Lapaix F, Phipps K, Edelsberg C, Zuna R, Mott LA and Dunn JL (1997) The significance of allelic deletions and aneuploidy in eolorectal carcinoma. Cancer 79:233-244
4. Dukes CE (1932) The classification of cancer of the rectum. J Pathol Bacterioal 35: 323-332
5. Freije JMP, Blay P, MacDonald NJ, Manrow RE and Steeg PS (1997) Site-directed mutation of NM23-H1. Mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro. J Biol Chem 272: 5525-5532
6. Indinnimeo M, Giarnieri E, Stazi A, Cicchini C, Brozzetti S, Valli C, Carreca I and Vecchione A (1997) Early stage human colorectal cancer: prognostic value of nm23-H1 protein overexpression. Cancer Lett 111: 1-5
7. Leone A, Flatow U, King CR, Sandeen MA, Margulies IM, Liotta LA and Steeg PS (1991a) Reduced tumor incidence, metastatic potential and cytoplasmic responsiveness of nm23 transfected melanoma cells. Cell 65: 25-35
8. Leone A, McBride OW, Weston A, Wang MG, Angland P, Cropp CS, Goepel JR, Lidereau R, Callahan R, Linehan WM, Rees RC, Harris CC, Liotta LA and Steeg PS (1991b) Somatic allelic deletions in nm23 in human cancer. Cancer Res 51: 2490-2493
9. Lindmark G (1996) NM23-H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer. Br J Cancer 11: 1413-1418
10. MacDonald NJ, Rosa ADL, Benedict MA, Freije JMP, Krutsch H and Steeg PS (1993) A serine phosphorylation of NM23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J Biol Chem 268: 25780-25789
11. Martinez JA, Prevot S, Nordlinger B, Nguyen TMA, Lacarriere Y, Munier A, Lascu I, Vaillant JC, Capeau J and Lacombe ML (1995) Overexpression of nm23-H1 and nm23-H2 genes in eolorectal carcinomas and loss of nm23-H1 expression in advanced tumor stages. Gut 37: 712-720
12. Myeroff LL and Maarkonitz SD (1993) Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential. J Natl Cancer Inst 85: 147-152
13. Rosa ADL, Williams RL and Steeg PS (1995) NM23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions. Bioessays 17:53-62
14. Royds JA, Cross SS, Silcocks PB, Scholefield JH, Rees RC and Stephenson TJ (1994) NM23 'anti-metastatic' gene product expression in colorectal carcinoma. J Pathol 172: 261-266
15. Ruiz P and Gunthert U (1996) The cellular basis of metastasis. World J Urol 14: 141-150
16. Stahl JA, Leone A, Rosengard AM, Porter L, King CR and Steeg PS (1991) Identification of a second human nm23 gene, nm23-H2. Cancer Res 51: 445-149
17. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Liotta LA and Sobel ME (1988) Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80: 200-204
18. Tannapfel A, Kockerling F, Katalinic A and Wittekind C (1995) Expression of NM23-H1 predicts lymph node involvement in eolorectal carcinoma. Dis Colon Rectum 38: 651-654
19. Wang L, Patel U, Ghosh L, Chen HC and Banerjee S (1993) Mutation in the nm23 gene is associated with metastasis in colorectal cancer. Cancer Res 53: 717-720
20. Whitelaw SC and Northover JMA ( 1994) The nm23 gene and colorectal cancer. Gut 35: 141
21. Yamaguchi A, Urano T, Fushida S, Furukawa K, Nishimura G, Yonemura Y, Miyazaki I, Nakagawara G and Shiku H (1993) Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis. Br J Cancer 68: 1020-1024
22. Zeng ZS, Hsu S, Zhang ZF, Cohen AM, Enker WE, Turnbull AA and Guillem JG (1994) High level of nm23-H1 gene expression is associated with local colorectal cancer progression not with metastasis. Br J Cancer 70: 1025-1030